Skip to main content
Top
Published in: BMC Public Health 1/2007

Open Access 01-12-2007 | Study protocol

Efficacy of confrontational counselling for smoking cessation in smokers with previously undiagnosed mild to moderate airflow limitation: study protocol of a randomized controlled trial

Authors: Daniel Kotz, Geertjan Wesseling, Marcus JH Huibers, Onno CP van Schayck

Published in: BMC Public Health | Issue 1/2007

Login to get access

Abstract

Background

The use of spirometry for early detection of chronic obstructive pulmonary disease (COPD) is still an issue of debate, particularly because of a lack of convincing evidence that spirometry has an added positive effect on smoking cessation. We hypothesise that early detection of COPD and confrontation with spirometry for smoking cessation may be effective when applying an approach we have termed "confrontational counselling"; a patient-centred approach which involves specific communication skills and elements of cognitive therapy. An important aspect is to confront the smoker with his/her airflow limitation during the counselling sessions. The primary objective of this study is to test the efficacy of confrontational counselling in comparison to regular health education and promotion for smoking cessation delivered by specialized respiratory nurses in current smokers with previously undiagnosed mild to moderate airflow limitation.

Methods/Design

The study design is a randomized controlled trial comparing confrontational counselling delivered by a respiratory nurse combined with nortriptyline for smoking cessation (experimental group), health education and promotion delivered by a respiratory nurse combined with nortriptyline for smoking cessation (control group 1), and "care as usual" delivered by the GP (control group 2). Early detection of smokers with mild to moderate airflow limitation is achieved by means of a telephone interview in combination with spirometry. Due to a comparable baseline risk of airflow limitation and motivation to quit smoking, and because of the standardization of number, duration, and scheduling of counselling sessions between the experimental group and control group 1, the study enables to assess the "net" effect of confrontational counselling. The study has been ethically approved and registered.

Discussion

Ethical as well as methodological considerations of the study are discussed in this protocol. A significant and relevant effect of confrontational counselling would provide an argument in favour of early detection of current smokers with airflow limitation. Successful treatment of tobacco dependence in respiratory patients requires repeated intensive interventions. The results of this study may also show that respiratory nurses are able to deliver this treatment and that intensive smoking cessation counselling is more feasible.

Trial registration:

Netherlands Trial Register (ISRCTN 64481813).
Appendix
Available only for authorised users
Literature
1.
go back to reference Global Initiative for Chronic Obstructive Lung Disease: Global strategy for the diagnosis, management, and prevention of chronic pulmonary disease. Executive summary. 2006, NHLBI / WHO Global Initiative for Chronic Obstructive Lung Disease: Global strategy for the diagnosis, management, and prevention of chronic pulmonary disease. Executive summary. 2006, NHLBI / WHO
2.
go back to reference WHO: The World Health Report. Reducing risks, promoting healthy life. 2002, Geneva , World Health Organisation WHO: The World Health Report. Reducing risks, promoting healthy life. 2002, Geneva , World Health Organisation
3.
go back to reference Murray CJL, Lopez AD: Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997, 349 (9064): 1498-1504. 10.1016/S0140-6736(96)07492-2.CrossRefPubMed Murray CJL, Lopez AD: Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997, 349 (9064): 1498-1504. 10.1016/S0140-6736(96)07492-2.CrossRefPubMed
4.
go back to reference Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001, 163 (5): 1256-1276.CrossRefPubMed Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001, 163 (5): 1256-1276.CrossRefPubMed
5.
go back to reference Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, Conway WA, Enright PL, Kanner RE, O'Hara P, et al: Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA. 1994, 272 (19): 1497-1505. 10.1001/jama.272.19.1497.CrossRefPubMed Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, Conway WA, Enright PL, Kanner RE, O'Hara P, et al: Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA. 1994, 272 (19): 1497-1505. 10.1001/jama.272.19.1497.CrossRefPubMed
6.
go back to reference Pauwels PRA, Rabe KF: Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet. 2004, 364 (9434): 613-620. 10.1016/S0140-6736(04)16855-4.CrossRefPubMed Pauwels PRA, Rabe KF: Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet. 2004, 364 (9434): 613-620. 10.1016/S0140-6736(04)16855-4.CrossRefPubMed
7.
go back to reference van Schayck CP, van der Heijden FMMA, van den Boom G, Tirimanna PRS, van Herwaarden CLA: Underdiagnosis of asthma: is the doctor or the patient to blame? The DIMCA project. Thorax. 2000, 55 (7): 562-565. 10.1136/thorax.55.7.562.CrossRefPubMedPubMedCentral van Schayck CP, van der Heijden FMMA, van den Boom G, Tirimanna PRS, van Herwaarden CLA: Underdiagnosis of asthma: is the doctor or the patient to blame? The DIMCA project. Thorax. 2000, 55 (7): 562-565. 10.1136/thorax.55.7.562.CrossRefPubMedPubMedCentral
8.
go back to reference Boushey H, Enright P, Samet J: Spirometry for Chronic Obstructive Pulmonary Disease Case Finding in Primary Care?. Am J Respir Crit Care Med. 2005, 172 (12): 1481-1482. 10.1164/rccm.2509009.CrossRefPubMed Boushey H, Enright P, Samet J: Spirometry for Chronic Obstructive Pulmonary Disease Case Finding in Primary Care?. Am J Respir Crit Care Med. 2005, 172 (12): 1481-1482. 10.1164/rccm.2509009.CrossRefPubMed
9.
go back to reference Enright PL, Studnicka M, Zielinski J: Spirometry to detect and manage chronic obstructive pulmonary disease and asthma in the primary care setting. Eur Resp Mon Lung Function Testing. 2005, 31: 1-14. Enright PL, Studnicka M, Zielinski J: Spirometry to detect and manage chronic obstructive pulmonary disease and asthma in the primary care setting. Eur Resp Mon Lung Function Testing. 2005, 31: 1-14.
10.
go back to reference White P: Should we use spirometry in the early detection of COPD?. Eur Respir J. 2005, 26 (3): 558-559. 10.1183/09031936.05.00061705.CrossRefPubMed White P: Should we use spirometry in the early detection of COPD?. Eur Respir J. 2005, 26 (3): 558-559. 10.1183/09031936.05.00061705.CrossRefPubMed
11.
go back to reference Wilt TJ, Niewoehner D, Kane RL, MacDonald R, Joseph AM: Spirometry as a motivational tool to improve smoking cessation rates: a systematic review of the literature. Nicotine & Tobacco Research. 2007, 9 (1): 21-32. 10.1080/14622200601078509.CrossRef Wilt TJ, Niewoehner D, Kane RL, MacDonald R, Joseph AM: Spirometry as a motivational tool to improve smoking cessation rates: a systematic review of the literature. Nicotine & Tobacco Research. 2007, 9 (1): 21-32. 10.1080/14622200601078509.CrossRef
12.
go back to reference Wilt TJ, Niewoehner D, Kim CB, Kane RL, Linabery A, Tacklind J, MacDonald R, Rutks I: Use of Spirometry for Case Finding, Diagnosis, and Management of Chronic Obstructive Pulmonary Disease (COPD). Evidence Report/Technology Assessment No. 121 (Prepared by the Minnesota Evidence-based Practice Center under Contract No. 290-02-0009.) AHRQ Publication No. 05-E017-2. 2005, Rockville, MD. , Agency for Healthcare Research and Quality Wilt TJ, Niewoehner D, Kim CB, Kane RL, Linabery A, Tacklind J, MacDonald R, Rutks I: Use of Spirometry for Case Finding, Diagnosis, and Management of Chronic Obstructive Pulmonary Disease (COPD). Evidence Report/Technology Assessment No. 121 (Prepared by the Minnesota Evidence-based Practice Center under Contract No. 290-02-0009.) AHRQ Publication No. 05-E017-2. 2005, Rockville, MD. , Agency for Healthcare Research and Quality
13.
go back to reference Enright P: Does screening for COPD by primary care physicians have the potential to cause more harm than good?. Chest. 2006, 129 (4): 833-835. 10.1378/chest.129.4.833.CrossRefPubMed Enright P: Does screening for COPD by primary care physicians have the potential to cause more harm than good?. Chest. 2006, 129 (4): 833-835. 10.1378/chest.129.4.833.CrossRefPubMed
14.
go back to reference Halpern MT: Effect of smoking characteristics on cognitive dissonance in current and former smokers. Addict Behav. 1994, 19 (2): 209-217. 10.1016/0306-4603(94)90044-2.CrossRefPubMed Halpern MT: Effect of smoking characteristics on cognitive dissonance in current and former smokers. Addict Behav. 1994, 19 (2): 209-217. 10.1016/0306-4603(94)90044-2.CrossRefPubMed
15.
go back to reference McMaster C, Lee C: Cognitive dissonance in tobacco smokers. Addictive Behaviors. 1991, 16: 349-353. 10.1016/0306-4603(91)90028-G.CrossRefPubMed McMaster C, Lee C: Cognitive dissonance in tobacco smokers. Addictive Behaviors. 1991, 16: 349-353. 10.1016/0306-4603(91)90028-G.CrossRefPubMed
16.
go back to reference Chapman S, Wong WL, Smith W: Self-exempting beliefs about smoking and health: differences between smokers and ex-smokers. American journal of public health. 1993, 83 (2): Chapman S, Wong WL, Smith W: Self-exempting beliefs about smoking and health: differences between smokers and ex-smokers. American journal of public health. 1993, 83 (2):
17.
go back to reference Lee C: Perceptions of immunity to disease in adult smokers. Journal of behavioral medicine. 1997, 12 (3): 267-277. 10.1007/BF00844871.CrossRef Lee C: Perceptions of immunity to disease in adult smokers. Journal of behavioral medicine. 1997, 12 (3): 267-277. 10.1007/BF00844871.CrossRef
18.
go back to reference McCoy SB, Gibbons FX, Reis TJ, Luus CAE, Von Wald Sufka A: Perceptions of smoking risk as a function of smoking status. Journal of behavioral medicine. 1992, 15 (5): 469-488. 10.1007/BF00844942.CrossRefPubMed McCoy SB, Gibbons FX, Reis TJ, Luus CAE, Von Wald Sufka A: Perceptions of smoking risk as a function of smoking status. Journal of behavioral medicine. 1992, 15 (5): 469-488. 10.1007/BF00844942.CrossRefPubMed
19.
go back to reference Peters JM, Ferris BG: Smoking, pulmonary function, and respiratory symptoms in a college-age group. Am Rev Respir Dis. 1967, 95 (5): 774-782.PubMed Peters JM, Ferris BG: Smoking, pulmonary function, and respiratory symptoms in a college-age group. Am Rev Respir Dis. 1967, 95 (5): 774-782.PubMed
20.
go back to reference Kotz D, Huibers MJ, Vos R, van Schayck CP, Wesseling G: Principles of confrontational counselling in smokers with chronic obstructive pulmonary disease (COPD). Med Hypotheses. 2007, 2007 Jun 27 [Epub ahead of print] Kotz D, Huibers MJ, Vos R, van Schayck CP, Wesseling G: Principles of confrontational counselling in smokers with chronic obstructive pulmonary disease (COPD). Med Hypotheses. 2007, 2007 Jun 27 [Epub ahead of print]
21.
go back to reference Fiore MC, Bailey WC, Cohen SJ, Dorfman SF, Goldstein MG, Gritz ER, et al: Treating tobacco use and dependence. Clinical Practical Guideline. 2000, Rockville, MD , US Department of Health and Human Services Fiore MC, Bailey WC, Cohen SJ, Dorfman SF, Goldstein MG, Gritz ER, et al: Treating tobacco use and dependence. Clinical Practical Guideline. 2000, Rockville, MD , US Department of Health and Human Services
22.
go back to reference Pieterse ME, Seydel ER, DeVries H, Mudde AN, Kok GJ, Halpern MT: Effectiveness of a minimal contact smoking cessation program for Dutch general practitioners: a randomized controlled trial. Prev Med. 2001, 32 (2): 182-190. 10.1006/pmed.2000.0791.CrossRefPubMed Pieterse ME, Seydel ER, DeVries H, Mudde AN, Kok GJ, Halpern MT: Effectiveness of a minimal contact smoking cessation program for Dutch general practitioners: a randomized controlled trial. Prev Med. 2001, 32 (2): 182-190. 10.1006/pmed.2000.0791.CrossRefPubMed
23.
go back to reference Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CPM, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J: Standardisation of spirometry. Eur Respir J. 2005, 26 (2): 319-338. 10.1183/09031936.05.00034805.CrossRefPubMed Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CPM, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J: Standardisation of spirometry. Eur Respir J. 2005, 26 (2): 319-338. 10.1183/09031936.05.00034805.CrossRefPubMed
24.
go back to reference Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, Grinten CPM, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J: General considerations for lung function testing. Eur Respir J. 2005, 26 (1): 153-161. 10.1183/09031936.05.00034505.CrossRefPubMed Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, Grinten CPM, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J: General considerations for lung function testing. Eur Respir J. 2005, 26 (1): 153-161. 10.1183/09031936.05.00034505.CrossRefPubMed
25.
go back to reference Zelen M: A new design for randomized clinical trials. The New England journal of medicine. 1979, 300 (22): 1242-1245.CrossRefPubMed Zelen M: A new design for randomized clinical trials. The New England journal of medicine. 1979, 300 (22): 1242-1245.CrossRefPubMed
26.
go back to reference Zelen M: Randomized consent designs for clinical trials: an update. Stat Med. 1990, 9 (6): 645-656. 10.1002/sim.4780090611.CrossRefPubMed Zelen M: Randomized consent designs for clinical trials: an update. Stat Med. 1990, 9 (6): 645-656. 10.1002/sim.4780090611.CrossRefPubMed
27.
go back to reference Torgerson DJ, Roland M: What is Zelen's design?. BMJ (Clinical research ed. 1998, 316 (7131): 606-CrossRef Torgerson DJ, Roland M: What is Zelen's design?. BMJ (Clinical research ed. 1998, 316 (7131): 606-CrossRef
28.
go back to reference STIVORO: De L-MIS: stoppen met roken voor longpatiënten. Handleiding voor longverpleegkundigen. [The L-MIS: smoking cessation in lung patients. Strategy for respiratory nurses.]. 2003, Den Haag , STIVORO STIVORO: De L-MIS: stoppen met roken voor longpatiënten. Handleiding voor longverpleegkundigen. [The L-MIS: smoking cessation in lung patients. Strategy for respiratory nurses.]. 2003, Den Haag , STIVORO
29.
go back to reference Kotz D, Huibers MJH, Vos R, van Schayck CP, Wesseling G: Principles of confrontational counselling in smokers with chronic obstructive pulmonary disease (COPD). Medical Hypotheses. 2007, In Press, Corrected Proof: Kotz D, Huibers MJH, Vos R, van Schayck CP, Wesseling G: Principles of confrontational counselling in smokers with chronic obstructive pulmonary disease (COPD). Medical Hypotheses. 2007, In Press, Corrected Proof:
31.
go back to reference Hughes JR, Stead LF, Lancaster T: Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2004 Hughes JR, Stead LF, Lancaster T: Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2004
32.
go back to reference Lancaster T, Stead LF: Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev. 2004 Lancaster T, Stead LF: Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev. 2004
33.
go back to reference Silagy C, Lancaster T, Stead LF, Mant D, Fowler G: Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2004 Silagy C, Lancaster T, Stead LF, Mant D, Fowler G: Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2004
34.
go back to reference Tonnesen P, Carrozzi L, Fagerstrom KO, Gratziou C, Jimenez-Ruiz C, Nardini S, Viegi G, Lazzaro C, Campell IA, Dagli E, West R: Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy. ERS task force guideline. Eur Respir J. 2007, 29 (2): 390-417. 10.1183/09031936.00060806.CrossRefPubMed Tonnesen P, Carrozzi L, Fagerstrom KO, Gratziou C, Jimenez-Ruiz C, Nardini S, Viegi G, Lazzaro C, Campell IA, Dagli E, West R: Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy. ERS task force guideline. Eur Respir J. 2007, 29 (2): 390-417. 10.1183/09031936.00060806.CrossRefPubMed
35.
go back to reference Wagena EJ, Knipschild P, Zeegers MPA: Should nortriptyline be used as a first-line aid to help smokers quit? Results from a systematic review and meta-analysis. Addiction (Abingdon, England). 2005, 100 (3): 317-326.CrossRef Wagena EJ, Knipschild P, Zeegers MPA: Should nortriptyline be used as a first-line aid to help smokers quit? Results from a systematic review and meta-analysis. Addiction (Abingdon, England). 2005, 100 (3): 317-326.CrossRef
36.
go back to reference Langone JJ, Gjika HB, Van Vunakis H: Nicotine and its metabolites. Radioimmunoassays for nicotine and cotinine. Biochemistry. 1973, 12 (24): 5025-5030. 10.1021/bi00748a032.CrossRefPubMed Langone JJ, Gjika HB, Van Vunakis H: Nicotine and its metabolites. Radioimmunoassays for nicotine and cotinine. Biochemistry. 1973, 12 (24): 5025-5030. 10.1021/bi00748a032.CrossRefPubMed
37.
go back to reference SRNT Subcommittee on Biochemical Verification: Biochemical verification of tobacco use and cessation. Nicotine and Tobacco Research. 2002, 4: 149-159. 10.1080/14622200210123581.CrossRef SRNT Subcommittee on Biochemical Verification: Biochemical verification of tobacco use and cessation. Nicotine and Tobacco Research. 2002, 4: 149-159. 10.1080/14622200210123581.CrossRef
38.
go back to reference Goossens MEJB, Molken MPMHR, Vlaeyen JWS, van der Linden SMJP: The cost diary: a method to measure direct and indirect costs in cost-effectiveness research. Journal of Clinical Epidemiology. 2000, 53 (7): 688-695. 10.1016/S0895-4356(99)00177-8.CrossRefPubMed Goossens MEJB, Molken MPMHR, Vlaeyen JWS, van der Linden SMJP: The cost diary: a method to measure direct and indirect costs in cost-effectiveness research. Journal of Clinical Epidemiology. 2000, 53 (7): 688-695. 10.1016/S0895-4356(99)00177-8.CrossRefPubMed
39.
go back to reference The EuroQol Group: EuroQol--a new facility for the measurement of health-related quality of life. Health Policy. 1990, 16 (3): 199-208. 10.1016/0168-8510(90)90421-9.CrossRef The EuroQol Group: EuroQol--a new facility for the measurement of health-related quality of life. Health Policy. 1990, 16 (3): 199-208. 10.1016/0168-8510(90)90421-9.CrossRef
40.
go back to reference Brooks R, the EuroQol Group: EuroQol: the current state of play. Health Policy. 1996, 37: 53-72. 10.1016/0168-8510(96)00822-6.CrossRefPubMed Brooks R, the EuroQol Group: EuroQol: the current state of play. Health Policy. 1996, 37: 53-72. 10.1016/0168-8510(96)00822-6.CrossRefPubMed
41.
go back to reference Mudde AN, Willemsen MC, Kremers S, Vries H: Meetinstrumenten voor onderzoek naar stoppen met roken. [Measurements for research on smoking cessation.]. 2000, Den Haag , Stivoro Mudde AN, Willemsen MC, Kremers S, Vries H: Meetinstrumenten voor onderzoek naar stoppen met roken. [Measurements for research on smoking cessation.]. 2000, Den Haag , Stivoro
42.
go back to reference Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO: The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991, 86 (9): 1119-1127. 10.1111/j.1360-0443.1991.tb01879.x.CrossRefPubMed Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO: The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991, 86 (9): 1119-1127. 10.1111/j.1360-0443.1991.tb01879.x.CrossRefPubMed
43.
go back to reference Price DB, Tinkelman DG, Nordyke RJ, Isonaka S, Halbert RJ, for the COPD Questionnaire Study Group: Scoring System and Clinical Application of COPD Diagnostic Questionnaires. Chest. 2006, 129 (6): 1531-1539. 10.1378/chest.129.6.1531.CrossRefPubMed Price DB, Tinkelman DG, Nordyke RJ, Isonaka S, Halbert RJ, for the COPD Questionnaire Study Group: Scoring System and Clinical Application of COPD Diagnostic Questionnaires. Chest. 2006, 129 (6): 1531-1539. 10.1378/chest.129.6.1531.CrossRefPubMed
44.
go back to reference Price DB, Tinkelman DG, Halbert RJ, Nordyke RJ, Isonaka S, Nonikov D, Juniper EF, Freeman D, Hausen T, Levy ML, Østrem A, van der Molen T, van Schayck CP: Symptom-based questionnaire for identifying chronic obstructive pulmonary disease in smokers. Respiration. 2006, 73: 285-295. 10.1159/000090142.CrossRefPubMed Price DB, Tinkelman DG, Halbert RJ, Nordyke RJ, Isonaka S, Nonikov D, Juniper EF, Freeman D, Hausen T, Levy ML, Østrem A, van der Molen T, van Schayck CP: Symptom-based questionnaire for identifying chronic obstructive pulmonary disease in smokers. Respiration. 2006, 73: 285-295. 10.1159/000090142.CrossRefPubMed
45.
go back to reference Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA: Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999, 54 (7): 581-586.CrossRefPubMedPubMedCentral Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA: Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999, 54 (7): 581-586.CrossRefPubMedPubMedCentral
46.
go back to reference Fletcher CM: Standardised questionnaire on respiratory symptoms: a statement prepared and approved by the MRC Committee on the Aetiology of Chronic Bronchitis (MRC breathlessness score). BMJ (Clinical research ed. 1960, 2: 1665- Fletcher CM: Standardised questionnaire on respiratory symptoms: a statement prepared and approved by the MRC Committee on the Aetiology of Chronic Bronchitis (MRC breathlessness score). BMJ (Clinical research ed. 1960, 2: 1665-
47.
go back to reference van der Molen T, Willemse BWM, Schokker S, Hacken NHT, Postma DS, Juniper EF: Development, validity and responsiveness of the Clinical COPD Questionnaire. Health and Quality of Life Outcomes. 2003, 1 (13): van der Molen T, Willemse BWM, Schokker S, Hacken NHT, Postma DS, Juniper EF: Development, validity and responsiveness of the Clinical COPD Questionnaire. Health and Quality of Life Outcomes. 2003, 1 (13):
48.
go back to reference van der Molen T, Willemse BW, Schokker S, Postma DS, Juniper EF: Development & cross sectional validity of the COPD symptom control questionnaire. Prim Care Resp J. 2001, 10 (3): 75- van der Molen T, Willemse BW, Schokker S, Postma DS, Juniper EF: Development & cross sectional validity of the COPD symptom control questionnaire. Prim Care Resp J. 2001, 10 (3): 75-
49.
go back to reference Ware JE, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992, 30 (6): 473-483. 10.1097/00005650-199206000-00002.CrossRefPubMed Ware JE, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992, 30 (6): 473-483. 10.1097/00005650-199206000-00002.CrossRefPubMed
50.
go back to reference McHorney CA, Ware JE, Raczek AE: The MOS 36-item short-form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Medical care. 1993, 31 (3): 247-263. 10.1097/00005650-199303000-00006.CrossRefPubMed McHorney CA, Ware JE, Raczek AE: The MOS 36-item short-form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Medical care. 1993, 31 (3): 247-263. 10.1097/00005650-199303000-00006.CrossRefPubMed
51.
go back to reference Williams JEA, Singh SJ, Sewell L, Guyatt GH, Morgan MDL: Development of a self-reported Chronic Respiratory Questionnaire (CRQ-SR). Thorax. 2001, 56 (12): 954-959. 10.1136/thorax.56.12.954.CrossRefPubMedPubMedCentral Williams JEA, Singh SJ, Sewell L, Guyatt GH, Morgan MDL: Development of a self-reported Chronic Respiratory Questionnaire (CRQ-SR). Thorax. 2001, 56 (12): 954-959. 10.1136/thorax.56.12.954.CrossRefPubMedPubMedCentral
52.
go back to reference Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW: A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987, 42 (10): 773-778.CrossRefPubMedPubMedCentral Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW: A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987, 42 (10): 773-778.CrossRefPubMedPubMedCentral
53.
go back to reference Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry. 1961, 4: 561-571.CrossRefPubMed Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry. 1961, 4: 561-571.CrossRefPubMed
54.
go back to reference Zigmond AS, Snaith RP: The Hospital Anxiety and Depression Scale. Acta Psyciatr Scan. 1983, 67: 361-370. 10.1111/j.1600-0447.1983.tb09716.x.CrossRef Zigmond AS, Snaith RP: The Hospital Anxiety and Depression Scale. Acta Psyciatr Scan. 1983, 67: 361-370. 10.1111/j.1600-0447.1983.tb09716.x.CrossRef
55.
go back to reference Spinhoven PH, Ormel J, Sloekers PPA, Kempen GIJM, Speckens AEM, van Hemert AM: A validation of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychological Medicine. 1997, 27: 363-370. 10.1017/S0033291796004382.CrossRefPubMed Spinhoven PH, Ormel J, Sloekers PPA, Kempen GIJM, Speckens AEM, van Hemert AM: A validation of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychological Medicine. 1997, 27: 363-370. 10.1017/S0033291796004382.CrossRefPubMed
56.
go back to reference Bjelland I, Dahl AA, Tangen Haug T, Neckelmann D: The validity of the Hospital Anxiety and Depression Scale. An updated literature review. Journal of Psychosomatic Research. 2002, 52: 69-77. 10.1016/S0022-3999(01)00296-3.CrossRefPubMed Bjelland I, Dahl AA, Tangen Haug T, Neckelmann D: The validity of the Hospital Anxiety and Depression Scale. An updated literature review. Journal of Psychosomatic Research. 2002, 52: 69-77. 10.1016/S0022-3999(01)00296-3.CrossRefPubMed
Metadata
Title
Efficacy of confrontational counselling for smoking cessation in smokers with previously undiagnosed mild to moderate airflow limitation: study protocol of a randomized controlled trial
Authors
Daniel Kotz
Geertjan Wesseling
Marcus JH Huibers
Onno CP van Schayck
Publication date
01-12-2007
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2007
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-7-332

Other articles of this Issue 1/2007

BMC Public Health 1/2007 Go to the issue